No medical records and no medical images were provided to the manufacturer.The lot number of the device was provided.The device history records are currently under review.The device has been returned for evaluation.The investigation is currently underway.The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
|
Manufacturing review: the device history records have been reviewed and this lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.This is the only complaint reported to date for this lot number and failure mode.Investigation summary: the device was returned for evaluation.A visual inspection found the outer layer peeled and fiber disturbance on the distal cone of the balloon.An attempt to inflated the device led to identifying both a complete circumferential rupture with a longitudinal rupture extending towards the distal tip.Therefore, the investigation is confirmed for the outer layer peeling, and fiber disturbance as well as for a compound rupture.However, the investigation is inconclusive for the reported retraction issue, as the device was unable to be fully functionally tested due to the returned sample condition.Per the reported event details, the user attempted to use a 7f merit introducer sheath for the procedure.The current instructions for use (ifu) states, "the minimal acceptable sheath french size is printed on the package label.Do not attempt to pass the pta catheter through a smaller size sheath introducer than indicated on the label." this device is labeled for use in a 8f sheath.It is possible that the compound rupture contributed to the identified outer layer of the balloon peeling and fiber issues.However, the definitive root cause for the identified issues could not be determined based on the available information.Labeling review: the review of the ifu (instructions for use), indications, warnings, precautions, cautions, possible complications, and contraindications showed that the product labeling is adequate.(b)(4).The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
|